JP2002517249A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002517249A5 JP2002517249A5 JP2000553593A JP2000553593A JP2002517249A5 JP 2002517249 A5 JP2002517249 A5 JP 2002517249A5 JP 2000553593 A JP2000553593 A JP 2000553593A JP 2000553593 A JP2000553593 A JP 2000553593A JP 2002517249 A5 JP2002517249 A5 JP 2002517249A5
- Authority
- JP
- Japan
- Prior art keywords
- ebv
- use according
- epitope
- sequence
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8915898P | 1998-06-12 | 1998-06-12 | |
| US60/089,158 | 1998-06-12 | ||
| PCT/US1999/013113 WO1999064603A2 (en) | 1998-06-12 | 1999-06-10 | ENHANCEMENT OF B CELL ACTIVATION AND IMMUNOGLOBULIN SECRETION BY CO-STIMULATION OF RECEPTORS FOR ANTIGEN AND EBV Gp350/220 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012116568A Division JP2012214477A (ja) | 1998-06-12 | 2012-05-22 | 抗原およびEBVGp350/220の受容体の同時刺激によるB細胞活性化および免疫グロブリン分泌の増強 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002517249A JP2002517249A (ja) | 2002-06-18 |
| JP2002517249A5 true JP2002517249A5 (cg-RX-API-DMAC7.html) | 2006-07-13 |
| JP5138844B2 JP5138844B2 (ja) | 2013-02-06 |
Family
ID=22216014
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000553593A Expired - Fee Related JP5138844B2 (ja) | 1998-06-12 | 1999-06-10 | 抗原およびEBVGp350/220の受容体の同時刺激によるB細胞活性化および免疫グロブリン分泌の増強 |
| JP2012116568A Pending JP2012214477A (ja) | 1998-06-12 | 2012-05-22 | 抗原およびEBVGp350/220の受容体の同時刺激によるB細胞活性化および免疫グロブリン分泌の増強 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012116568A Pending JP2012214477A (ja) | 1998-06-12 | 2012-05-22 | 抗原およびEBVGp350/220の受容体の同時刺激によるB細胞活性化および免疫グロブリン分泌の増強 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6432679B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1086231A2 (cg-RX-API-DMAC7.html) |
| JP (2) | JP5138844B2 (cg-RX-API-DMAC7.html) |
| AU (1) | AU762799B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2331258C (cg-RX-API-DMAC7.html) |
| WO (1) | WO1999064603A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6248334B1 (en) * | 1997-01-08 | 2001-06-19 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this process |
| AU762799B2 (en) * | 1998-06-12 | 2003-07-03 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Enhancement of B cell activation and immunoglobulin secretion by co-stimulation of receptors for antigen and EBV Gp350/220 |
| FR2819724B1 (fr) * | 2001-01-22 | 2005-05-13 | Inst Necker | Moyens pour induire une reponse immune aux antigenes bacteriens polysccharidiques et aux structures proteiques des capsides de virus |
| US6820011B2 (en) * | 2001-04-11 | 2004-11-16 | The Regents Of The University Of Colorado | Three-dimensional structure of complement receptor type 2 and uses thereof |
| GB0210682D0 (en) * | 2002-05-09 | 2002-06-19 | Glaxosmithkline Biolog Sa | Novel use |
| EP1539811A4 (en) * | 2002-09-16 | 2006-05-24 | Elusys Therapeutics Inc | PREPARATION OF BISPEQIFIC MOLECULES WITH POLYETHYLENE GLYCOL LINKER |
| CN100594037C (zh) | 2002-11-15 | 2010-03-17 | Musc研究发展基金会 | 通过补体受体2定向的补体调节剂 |
| EP1599170B1 (en) * | 2003-02-21 | 2013-01-16 | Hasumi Llc (Dba Shukokai International) | Human lymphocyte vaccine adjuvant |
| CA2556169C (en) * | 2004-01-29 | 2011-11-22 | Andrew Lees | Use of amino-oxy functional groups in the preparation of vaccines |
| AU2006329215A1 (en) * | 2005-12-22 | 2007-06-28 | Conjuchem Biotechnologies Inc. | Process for the production of preformed conjugates of albumin and a therapeutic agent |
| JP5250548B2 (ja) * | 2006-06-21 | 2013-07-31 | エムユーエスシー ファウンデーション フォー リサーチ ディベロップメント | 疾患の治療のための補体h因子の標的化 |
| AU2010268367B2 (en) | 2009-07-02 | 2016-10-20 | Ith Immune Therapy Holdings Ab | Exosome based treatment of cancer |
| JP5871798B2 (ja) | 2009-07-02 | 2016-03-01 | エムユーエスシー ファウンデーション フォー リサーチ ディベロップメント | 肝再生を刺激する方法 |
| WO2011017101A2 (en) | 2009-07-27 | 2011-02-10 | Fina Biosolutions, Llc | Method for producing protein-carbohydrate vaccines reduced in free carbohydrate |
| CN102958535A (zh) | 2009-11-05 | 2013-03-06 | 亚力史剑桥公司 | 阵发性夜间血红蛋白尿、溶血性贫血和涉及血管内和血管外溶血的疾病状态的治疗 |
| BR122022002139B1 (pt) | 2009-12-17 | 2022-08-23 | Fina Biosolutions, Llc | Processo de conjugação de carboidratos na preparação de vacinas conjugadas e suas respectivas vacinas |
| ES2743156T3 (es) | 2010-04-23 | 2020-02-18 | Serum Institute Of India Pvt Ltd | Método simple para eliminación simultánea de múltiples impurezas a partir de sobrenadantes de cultivo a niveles ultrabajos |
| MX2012013233A (es) | 2010-05-14 | 2013-05-20 | Univ Colorado Regents | Grupos que apuntan a receptor 2 de complemento (cr2) mejorados. |
| BR112012033119A2 (pt) | 2010-06-22 | 2016-10-25 | Univ Colorado Regents | anticorpos para o fragamento c3d do componente do complemento 3. |
| EP2877205A4 (en) * | 2012-07-26 | 2016-04-06 | Jackson H M Found Military Med | VACCINE WITH A MULTIMED FUSION PROTEIN AND IMMUNOTHERAPY |
| JP2015535212A (ja) | 2012-08-17 | 2015-12-10 | ザ・リージエンツ・オブ・ザ・ユニバーシテイ・オブ・コロラド、ア・ボデイー・コーポレイト | 補体活性化を検出するための組成物および方法 |
| US10413620B2 (en) | 2012-08-17 | 2019-09-17 | The Regents Of The University Of Colorado, A Body Corporate | Light-emitting versions of the monoclonal antibody to C3D (MAB 3D29) for imaging |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4486530A (en) | 1980-08-04 | 1984-12-04 | Hybritech Incorporated | Immunometric assays using monoclonal antibodies |
| US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| US4737462A (en) | 1982-10-19 | 1988-04-12 | Cetus Corporation | Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β |
| US4518584A (en) | 1983-04-15 | 1985-05-21 | Cetus Corporation | Human recombinant interleukin-2 muteins |
| US5011912A (en) | 1986-12-19 | 1991-04-30 | Immunex Corporation | Hybridoma and monoclonal antibody for use in an immunoaffinity purification system |
| AU4341189A (en) * | 1988-10-03 | 1990-05-01 | Scripps Clinic And Research Foundation | The receptor binding region of ebvgp350 |
| US5280113A (en) | 1989-08-16 | 1994-01-18 | Monsanto Company | Method for producing synthetic N-linked glycoconjugates |
| US5310729A (en) | 1990-04-20 | 1994-05-10 | California Institute Of Biological Research | Interferon-related polypeptides as CR2 ligands and their use for modulating immune cell functions |
| US5331090A (en) | 1989-09-08 | 1994-07-19 | California Institute Of Biological Research | CR2 ligand compositions and methods for modulating immune cell functions |
| EP0625910B1 (en) | 1992-02-11 | 2003-07-23 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Dual carrier immunogenic construct |
| WO1993019092A1 (fr) * | 1992-03-19 | 1993-09-30 | Centre National De La Recherche Scientifique | Adenovirus recombinants defectifs exprimant des proteines caracteristiques du virus epstein-barr |
| US5521066A (en) | 1993-09-13 | 1996-05-28 | Bristol-Myers Squibb Company | Periplasmic membrane-bound system for detecting protein-protein interactions |
| EP0720485B1 (en) | 1993-09-22 | 2003-11-19 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Method of activating soluble carbohydrate using novel cyanylating reagents for the production of immunogenic constructs |
| MY114769A (en) | 1994-04-18 | 2003-01-31 | Aviron Inc | Non-splicing variants of gp350/220 |
| GB9424631D0 (en) | 1994-12-06 | 1995-01-25 | Lynxvale Ltd | Modulating the immune response |
| US5712149A (en) | 1995-02-03 | 1998-01-27 | Cell Genesys, Inc. | Chimeric receptor molecules for delivery of co-stimulatory signals |
| DE69628418T2 (de) * | 1995-03-22 | 2004-04-01 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Herstellung von immunogenen konstrukten unter verwendung von löslichen kohlehydraten, die durch organische cyanylierungs-reagenzien aktiviert wurden |
| AU762799B2 (en) * | 1998-06-12 | 2003-07-03 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Enhancement of B cell activation and immunoglobulin secretion by co-stimulation of receptors for antigen and EBV Gp350/220 |
-
1999
- 1999-06-10 AU AU45594/99A patent/AU762799B2/en not_active Ceased
- 1999-06-10 WO PCT/US1999/013113 patent/WO1999064603A2/en not_active Ceased
- 1999-06-10 EP EP19990928550 patent/EP1086231A2/en not_active Withdrawn
- 1999-06-10 US US09/328,599 patent/US6432679B1/en not_active Expired - Lifetime
- 1999-06-10 JP JP2000553593A patent/JP5138844B2/ja not_active Expired - Fee Related
- 1999-06-10 CA CA 2331258 patent/CA2331258C/en not_active Expired - Fee Related
-
2012
- 2012-05-22 JP JP2012116568A patent/JP2012214477A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Virelizier et al. | Antibody responses to antigenic determinants of influenza virus hemagglutinin: I. Thymus dependence of antibody formation and thymus independence of immunological memory | |
| CN112521511B (zh) | 一种含EB病毒gB蛋白的自组装纳米颗粒及其制备方法与应用 | |
| JP2858848B2 (ja) | B型肝炎ウイルスコア抗原粒子 | |
| JP2528815B2 (ja) | 多効果免疫性蛋白質 | |
| Perham et al. | Engineering a peptide epitope display system on filamentous bacteriophage | |
| JP2002532387A (ja) | ペプチドリガンドを介して結合された複数の免疫原性成分を有するhbvコア抗原粒子 | |
| JPH063445B2 (ja) | 抗原活性アミノ酸連鎖の決定方法 | |
| CA2331846A1 (en) | Expression vectors for stimulating an immune response and methods of using the same | |
| JP2002520000A5 (cg-RX-API-DMAC7.html) | ||
| JP2003530123A (ja) | B型肝炎コア抗原融合タンパク質 | |
| WO1984003506A1 (en) | Antigenically active amino acid sequences | |
| JPS63218627A (ja) | ロタウイルスヌクレオキャプシドタンパクvp6のワクチン組成物への使用 | |
| CN1972710B (zh) | 包含噬菌体纳米颗粒的方法和组合物 | |
| CA2331258A1 (en) | Enhancement of b cell activation and immunoglobulin secretion by co-stimulation of receptors for antigen and ebv gp350/220 | |
| Redmond et al. | Rotavirus particles function as immunological carriers for the delivery of peptides from infectious agents and endogenous proteins | |
| US20130295131A1 (en) | Generation of antigenic virus-like particles through protein-protein linkages | |
| WO1997020854A9 (en) | Recombinant gas vesicles and uses thereof | |
| WO1997020854A1 (en) | Recombinant gas vesicles and uses thereof | |
| CN121449698A (zh) | 分子胶及纳米颗粒疫苗组合物 | |
| CN116271066A (zh) | 一种重组腺病毒载体疫苗吸入给药递送系统 | |
| JP2002515249A5 (cg-RX-API-DMAC7.html) | ||
| CN118286410B (zh) | 一种偶联CD8抗体的肿瘤mRNA疫苗的制备方法 | |
| CN117797252B (zh) | 一种基于dna纳米技术的病毒多肽-蛋白亚单位组合疫苗及其制备方法和应用 | |
| Sjolander et al. | Bacterial Expression Systems Based on a Protein A and Protein G Designed for the Production of Immunogens: Applications to Plasmodium falciparum Malaria Antigens | |
| CN118576725A (zh) | 一种以arc蛋白为载体的纳米颗粒及其制备方法和应用 |